#immunotherapies — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #immunotherapies, aggregated by home.social.
-
New research reveals that cells in blood vessels in the #liver start a "sleep timer" that switches off #ImmuneCells in #ChronicHepatitisB. Targeting this mechanism could be a starting point for new #immunotherapies: http://go.tum.de/857974
📷A. Heddergott
-
Special #seminar this Thursday, 4/4, at noon EST with Jason George from Texas A&M. Dr. George will discuss #biophysical and stochastic modeling of the tumor-immune interaction for optimizing T cell #immunotherapies. And you can join here:
-
A molecule made by #Streptococcus #pyogenes — the #bacterium that causes #strep throat — could help explain the origins of enigmatic #autoimmune diseases such as #rheumatic fever and #lupus. Findings illuminate why century-old #cancer #immunotherapies showed promise and why modern immune therapies for cancer don’t work as often as they could.
#Biology #Chemistry #Medical #Microbiology #sflorg
https://www.sflorg.com/2023/10/bio10072301.html -
A research group at the University of Basel has identified a #gene that drives T #lymphocytes (#Tcell) to exhaustion. This finding opens up new approaches for more effective #immunotherapies.
#Biology #Medical #sflorg
https://www.sflorg.com/2023/02/bio02022301.html -
CW: Immune Organoid Company Raises $4.3M in Seed Funds
A new company developing 3-D cell and tissue models of lymph nodes for discovery of #immunotherapies is raising $4.3 million in seed funds. https://sciencebusiness.technewslit.com/?p=44244 #Science #Business #Organoids #ImmuneSystem #LymphNodes #StartUp #AnimalTesting #DrugDiscovery #Finance #VentureCapital #SeedFunds
-
This week's special issue on #CellEngineering in #Science (@sciencemagazine) includes:
• a review on future of engineered #immunotherapies by Darrell Irvine, Marcela Maus, David Mooney, & Wilson Wong: https://bit.ly/Sci_abq6990
• a piece on engineering #bacteria for anti- #cancer therapies by
Candice Gurbati, Nick Arpaia, & Tal Danino: https://bit.ly/Sci_add9667Be sure to also check out the introduction written by my fantastic colleagues Bryan Ray & Priscilla Kelly: https://bit.ly/Sci_adf8627
-
CW: Biotech, Regeneron in $2B Cancer Antibody Deal
A developer of #cancer treatments triggered by #tumor #chemistry is partnering with biologic drug maker Regeneron on dual-action cancer #immunotherapies. https://sciencebusiness.technewslit.com/?p=44129 #Science #Business #Biotechnology #Collaboration #Microenvironment #Antibodies
-
Interesting article on findings by @[email protected] combining #oncolytic #viruses with #immunotherapies to treat patients with resistant #tumors. E.g. our member Ulrich Lauer has done promising research on smallpox #vaccine viruses against peritoneal #cancer
https://www.fr.de/wissen/viren-gegen-krebs-foschung-studien-therapie-news-91782858.html